DexCom, Inc. (LON: 0A4M)
London
· Delayed Price · Currency is GBP · Price in USD
86.65
+2.29 (2.72%)
At close: Jan 21, 2025
DexCom Revenue
DexCom had revenue of $994.20M USD in the quarter ending September 30, 2024, with 1.97% growth. This brings the company's revenue in the last twelve months to $3.95B, up 16.19% year-over-year. In the year 2023, DexCom had annual revenue of $3.62B with 24.49% growth.
Revenue (ttm)
$3.95B
Revenue Growth
+16.19%
P/S Ratio
n/a
Revenue / Employee
$411.88K
Employees
9,600
Market Cap
27.62B GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 3.62B | 712.50M | 24.49% |
Dec 31, 2022 | 2.91B | 461.30M | 18.84% |
Dec 31, 2021 | 2.45B | 521.80M | 27.08% |
Dec 31, 2020 | 1.93B | 450.70M | 30.54% |
Dec 31, 2019 | 1.48B | 444.40M | 43.08% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 38.20B |
Shell | 221.41B |
HSBC Holdings | 43.25B |
Unilever | 51.12B |
Rio Tinto Group | 42.87B |
RELX PLC | 9.30B |
BP p.l.c. | 144.69B |
British American Tobacco p.l.c. | 26.18B |